Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 3
2013 3
2014 4
2015 3
2016 11
2017 17
2018 18
2019 16
2020 10
2021 16
2022 3
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Non-rhabdomyosarcoma soft-tissue sarcoma.
Milgrom SA, Million L, Mandeville H, Safwat A, Ermoian RP, Terezakis S. Milgrom SA, et al. Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28279. doi: 10.1002/pbc.28279. Pediatr Blood Cancer. 2021. PMID: 33818885 Review.
The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group.
Constine LS, Yahalom J, Ng AK, Hodgson DC, Wirth A, Milgrom SA, Mikhaeel NG, Eich HT, Illidge T, Ricardi U, Dieckmann K, Moskowitz CH, Advani R, Mauch PM, Specht L, Hoppe RT. Constine LS, et al. Among authors: milgrom sa. Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1100-1118. doi: 10.1016/j.ijrobp.2018.01.011. Epub 2018 Jan 9. Int J Radiat Oncol Biol Phys. 2018. PMID: 29722655 Free article. Review.
SMILE and Beam On.
Milgrom SA, Haverkos BM. Milgrom SA, et al. Int J Radiat Oncol Biol Phys. 2021 Dec 1;111(5):1105. doi: 10.1016/j.ijrobp.2021.09.045. Int J Radiat Oncol Biol Phys. 2021. PMID: 34793729 No abstract available.
International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Binkley MS, Flerlage JE, Savage KJ, Akhtar S, Steiner R, Zhang XY, Dickinson M, Prica A, Major A, Hendrickson PG, Hopkins D, Ng A, Casulo C, Baron J, Roberts KB, Al Kendi J, Balogh A, Ricardi U, Torka P, Specht L, De Silva R, Pickard K, Blazin LJ, Henry M, Smith CM, Halperin D, Brady J, Brennan B, Senchenko MA, Reeves M, Hoppe BS, Terezakis S, Talaulikar D, Picardi M, Kirova Y, Fergusson P, Hawkes EA, Lee D, Doo NW, Barraclough A, Cheah CY, Ku M, Hamad N, Mutsando H, Gilbertson M, Marconi T, Viiala N, Maurer MJ, Eichenauer DA, Hoppe RT; GLOW Consortium. Binkley MS, et al. J Clin Oncol. 2024 Mar 26:JCO2301655. doi: 10.1200/JCO.23.01655. Online ahead of print. J Clin Oncol. 2024. PMID: 38531001
A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma.
Milgrom SA, Elhalawani H, Lee J, Wang Q, Mohamed ASR, Dabaja BS, Pinnix CC, Gunther JR, Court L, Rao A, Fuller CD, Akhtari M, Aristophanous M, Mawlawi O, Chuang HH, Sulman EP, Lee HJ, Hagemeister FB, Oki Y, Fanale M, Smith GL. Milgrom SA, et al. Sci Rep. 2019 Feb 4;9(1):1322. doi: 10.1038/s41598-018-37197-z. Sci Rep. 2019. PMID: 30718585 Free PMC article.
92 results